Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
KV Petitions FDA To Retain 180-Day Exclusivity For Generic Toprol-XL Doses
Oct 24 2006
•
By
Daniel Fowler
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Archive
More from Pink Sheet